Fonte: Journal of Psychiatric Research. Unidade: FM
Assuntos: DEPRESSÃO (TERAPIA;ENZIMOLOGIA), PLAQUETAS SANGUÍNEAS, BIOMARCADORES, ANTIDEPRESSIVOS ( USO TERAPÊUTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAQUIM, Helena P. G. et al. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. Journal of Psychiatric Research, v. 46, n. 8, p. 1053-1058, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2012.04.020. Acesso em: 06 out. 2024.APA
Joaquim, H. P. G., Talib, L. L., Forlenza, O. V., Diniz, B. S., & Gattaz, W. F. (2012). Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. Journal of Psychiatric Research, 46( 8), 1053-1058. doi:10.1016/j.jpsychires.2012.04.020NLM
Joaquim HPG, Talib LL, Forlenza OV, Diniz BS, Gattaz WF. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 8): 1053-1058.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.04.020Vancouver
Joaquim HPG, Talib LL, Forlenza OV, Diniz BS, Gattaz WF. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 8): 1053-1058.[citado 2024 out. 06 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.04.020
